Torres-Rendon et al. [68] analyzed the MCM2 expression in clinical samples of oral squamous cell carcinoma using immunohistochemistry and demonstrated that MCM2 might be a useful prognostic marker for the disease. This evidence concerns the gene MCM2 and oral cavity squamous cell carcinoma.